SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Ind-Swift Laboratories gains on entering into joint venture to explore opportunities in pharmaceutical field

24 Jun 2022 Evaluate

Ind-Swift Laboratories is currently trading at Rs. 59.60, up by 1.10 points or 1.88% from its previous closing of Rs. 58.50 on the BSE.

The scrip opened at Rs. 60.55 and has touched a high and low of Rs. 60.55 and Rs. 59.15 respectively. So far 623 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 127.35 on 20-Jul-2021 and a 52 week low of Rs. 51.10 on 31-May-2022.

Last one week high and low of the scrip stood at Rs. 60.90 and Rs. 57.35 respectively. The current market cap of the company is Rs. 349.50 crore.

The promoters holding in the company stood at 42.00%, while Institutions and Non-Institutions held 19.55% and 38.44% respectively.

Ind-Swift Laboratories has entered into a Joint Venture, which shall be operated through a newly incorporated entity viz MJM Remedies, where the Company shall have 75% stake and rest 25% stake shall be held by Ramesh Mehta. The new joint venture will explore the opportunities in the pharmaceutical field. MJM Remedies belongs to pharmaceutical industry.

Ind-Swift Laboratories is global manufacturer of Active Pharmaceutical Ingredients (API), Intermediates and formulations (through group collaboration).

Ind-Swift Lab. Share Price

132.00 -13.30 (-9.15%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×